{"product_id":"donotage-pure-berberine-supplement","title":"DoNotAge Berberine Review: 500 mg Capsules, Evidence and Value","description":"\u003cp\u003eThis DoNotAge Berberine review evaluates our preferred straightforward conventional capsule: 500 mg per capsule, a simple HCl formulation and manufacturer-reported batch testing. It is an appealing product for a reader who has already decided, with appropriate clinical input, that berberine fits a measurable metabolic goal.\u003c\/p\u003e\n\u003cp\u003eOur recommendation is about the product proposition. It is not a claim that the current retail bottle has been proven to produce every benefit in the wider literature. Biohack Blueprint is a DoNotAge affiliate and may earn commission from qualifying purchases.\u003c\/p\u003e\n\u003ch2 id=\"our-editorial-verdict\"\u003eOur editorial verdict\u003c\/h2\u003e\n\u003cp\u003eWe rate the product \u003cstrong\u003e5\/5 for a clear set of product-selection criteria: a straightforward conventional HCl option with clear unit dosing, a simple formula, accessible quality-documentation route and competitive starting-price context\u003c\/strong\u003e. This is a subjective product-fit recommendation, not a clinical-efficacy score, independent purity assay or blinded market-wide test.\u003c\/p\u003e\n\u003cp\u003eThe strongest reasons to choose it are practical. It is easy to understand what one capsule supplies, the form is closer to several important conventional-berberine trials than an unspecified blend, and the manufacturer offers product-specific information and a route to request certificates of analysis.\u003c\/p\u003e\n\u003ch2 id=\"current-product-facts\"\u003eCurrent product facts\u003c\/h2\u003e\n\u003cdiv class=\"bb-table-wrap\" style=\"overflow-x:auto\"\u003e\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth scope=\"col\"\u003eDetail\u003c\/th\u003e\n\u003cth scope=\"col\"\u003eOfficial information checked October 22, 2026\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIngredient\u003c\/td\u003e\n\u003ctd\u003eBerberine HCl\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapsule amount\u003c\/td\u003e\n\u003ctd\u003e500 mg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePurity statement\u003c\/td\u003e\n\u003ctd\u003e98%, according to the product quality section\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapsule shell\u003c\/td\u003e\n\u003ctd\u003eHPMC, described as plant-based\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdded fillers\u003c\/td\u003e\n\u003ctd\u003eManufacturer states none\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePack choices\u003c\/td\u003e\n\u003ctd\u003e60 and 366 capsules\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisplayed US starting price\u003c\/td\u003e\n\u003ctd\u003eFrom $24; options and regions differ\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTesting\u003c\/td\u003e\n\u003ctd\u003eManufacturer states in-house and third-party testing; CoAs on request\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003cp\u003eThe source is the \u003ca href=\"https:\/\/donotage.org\/pure-berberine\" rel=\"noopener\" target=\"_blank\"\u003eofficial product page\u003c\/a\u003e. We have not independently laboratory-assayed the current retail lot. The current product page states 98% purity; specifications for other DoNotAge ingredients do not describe this product.\u003c\/p\u003e\n\u003ch2 id=\"why-the-formulation-makes-sense\"\u003eWhy the formulation makes sense\u003c\/h2\u003e\n\u003cp\u003eConventional berberine has been studied in human glucose and lipid research. A 116-participant placebo-controlled trial used 1 g\/day, while other studies used different regimens. The ingredient has a meaningful research base, although its limitations should remain visible. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-18397984\" aria-label=\"Research source 1\"\u003e[1]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-18442638\" aria-label=\"Research source 2\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-33024120\" aria-label=\"Research source 3\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eA 500 mg capsule makes arithmetic straightforward, but capsule strength does not establish the right daily amount for a particular person. The official FAQ currently describes 500–1,000 mg\/day as typical and advises taking it with a meal. Subscription quantities for larger intakes are supply options, not a clinical dosing endorsement.\u003c\/p\u003e\n\u003ch2 id=\"blood-sugar-the-most-relevant-positive-evidence\"\u003eBlood sugar: the most relevant positive evidence\u003c\/h2\u003e\n\u003cp\u003eControlled studies support improvements in selected glucose-related markers in people with type 2 diabetes. PREMOTE reported a berberine-alone HbA1c change of about -0.99 percentage points versus -0.59 with placebo, a difference of roughly 0.40 percentage points. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-33024120\" aria-label=\"Research source 3\"\u003e[3]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eThat is useful evidence for the ingredient and research regimen. It does not establish that this exact DoNotAge bottle was tested, that every buyer will respond or that a person should replace prescribed treatment.\u003c\/p\u003e\n\u003cp\u003eA small prediabetes pilot using a different branded preparation was encouraging, but it did not establish long-term diabetes prevention. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-37679692\" aria-label=\"Research source 4\"\u003e[4]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003ch2 id=\"cholesterol-promising-marker-findings\"\u003eCholesterol: promising marker findings\u003c\/h2\u003e\n\u003cp\u003eThe lipid literature includes early mechanistic studies, randomized work and newer apoB-related research. These findings make an identified lipid goal a reasonable subject for clinical discussion. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-15531889\" aria-label=\"Research source 5\"\u003e[5]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-36941490\" aria-label=\"Research source 6\"\u003e[6]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-42470424\" aria-label=\"Research source 7\"\u003e[7]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eThey do not establish the same clinical-event protection as every established lipid therapy. The product recommendation concerns the capsule's label and proposition; the strength of evidence differs by endpoint.\u003c\/p\u003e\n\u003ch2 id=\"weight-and-fatty-liver-set-the-expectation-correctly\"\u003eWeight and fatty liver: set the expectation correctly\u003c\/h2\u003e\n\u003cp\u003eThe updated obesity synthesis estimated a small average weight difference of about 0.88 kg. BRAVO then found no significant benefit for its primary visceral-fat and liver-fat outcomes after six months of conventional berberine HCl. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-41310257\" aria-label=\"Research source 8\"\u003e[8]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-41543854\" aria-label=\"Research source 9\"\u003e[9]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eThese results do not make a well-specified capsule a poor product. They do mean it should be purchased for a realistic, relevant objective rather than a guaranteed transformation, selective belly-fat loss or a liver cleanse.\u003c\/p\u003e\n\u003cp\u003eEarlier fatty-liver findings and combination research involve different designs and interventions. HTD1801, an investigational berberine ursodeoxycholate compound, is not the same as this HCl capsule. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-26252777\" aria-label=\"Research source 10\"\u003e[10]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-40029660\" aria-label=\"Research source 11\"\u003e[11]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003ch2 id=\"longevity-and-mechanism\"\u003eLongevity and mechanism\u003c\/h2\u003e\n\u003cp\u003eExperimental work connects berberine with mitochondrial complex-I inhibition and AMPK-related signaling. Mouse and worm studies provide further scientific interest, but human lifespan extension is not established. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-18285556\" aria-label=\"Research source 12\"\u003e[12]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-31773901\" aria-label=\"Research source 13\"\u003e[13]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-40338239\" aria-label=\"Research source 14\"\u003e[14]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eA clean, practical formulation does not need an exaggerated life-extension claim to be worth considering. Product quality and evidence strength should be evaluated separately.\u003c\/p\u003e\n\u003ch2 id=\"testing-and-the-certificate-of-analysis\"\u003eTesting and the certificate of analysis\u003c\/h2\u003e\n\u003cp\u003eDoNotAge states that its batches are tested in-house and by third parties and that certificates are available on request. That is a useful transparency route. Buyers should ask for documentation matching the actual product and lot, including identity, potency and relevant contaminant testing.\u003c\/p\u003e\n\u003cp\u003eA historical assay of commercial berberine preparations found substantial potency variation. It explains why verification matters, but it does not rank today's DoNotAge lot or prove that every competing brand is inferior. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-28792254\" aria-label=\"Research source 15\"\u003e[15]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eOur assessment uses published information and source review, not a laboratory comparison performed by Biohack Blueprint. This distinction is part of the recommendation, not a reason to ignore the manufacturer's quality process.\u003c\/p\u003e\n\u003ch2 id=\"dose-tolerance-and-medicines\"\u003eDose, tolerance and medicines\u003c\/h2\u003e\n\u003cp\u003eThe \u003ca href=\"\/blogs\/berberine\/berberine-dosage\"\u003edosage guide\u003c\/a\u003e compares actual study amounts, while the \u003ca href=\"\/blogs\/berberine\/best-time-to-take-berberine\"\u003etiming guide\u003c\/a\u003e explains the meal instructions. Do not increase intake simply because a research paper or subscription selector lists a larger amount.\u003c\/p\u003e\n\u003cp\u003eDigestive effects are possible. Repeated berberine exposure affected CYP enzymes in a human study, and cyclosporine interaction research demonstrates why a medication review matters. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-18442638\" aria-label=\"Research source 2\"\u003e[2]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-21870106\" aria-label=\"Research source 16\"\u003e[16]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-16133554\" aria-label=\"Research source 17\"\u003e[17]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003ePregnancy and breastfeeding use is generally avoided; preconception questions need individual advice. Rare cardiac-rhythm reports warrant proportionate attention, particularly in susceptible people, without being treated as a measured population incidence. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-8513024\" aria-label=\"Research source 18\"\u003e[18]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-42488242\" aria-label=\"Research source 19\"\u003e[19]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-42698826\" aria-label=\"Research source 20\"\u003e[20]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003ch2 id=\"who-is-it-most-suitable-for\"\u003eWho is it most suitable for?\u003c\/h2\u003e\n\u003cp\u003eThe strongest fit is an adult seeking a clearly specified conventional capsule for an identified metabolic goal, after appropriate medicine and health review. It also suits a buyer who values a simple formula and wants a direct route to manufacturer documentation.\u003c\/p\u003e\n\u003cp\u003eIt is a poor fit for someone seeking a guaranteed weight-loss result, a replacement for necessary medicine, a proven fertility treatment or a validated human life-extension intervention. PCOS evidence and pregnancy safety need their own assessment. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-42836929\" aria-label=\"Research source 21\"\u003e[21]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-27336209\" aria-label=\"Research source 22\"\u003e[22]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003ch2 id=\"how-it-compares\"\u003eHow it compares\u003c\/h2\u003e\n\u003cp\u003eThorne's dual-form product combines HCl with a Phytosome ingredient; NOW and Integrative Therapeutics offer conventional options with different pack and excipient details. These are product-design comparisons, not a head-to-head clinical ranking.\u003c\/p\u003e\n\u003cp\u003eEnhanced absorption can be relevant, but the larger exposure in a small formulation study is not proof of proportionately greater metabolic benefit. A tiny DHB pilot found no significant acute glycemic advantage despite exposure differences. \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-34904017\" aria-label=\"Research source 23\"\u003e[23]\u003c\/a\u003e\u003c\/sup\u003e \u003csup\u003e\u003ca href=\"\/blogs\/research\/berberine-35010998\" aria-label=\"Research source 24\"\u003e[24]\u003c\/a\u003e\u003c\/sup\u003e\u003c\/p\u003e\n\u003cp\u003eOur \u003ca href=\"\/blogs\/berberine\/best-berberine-supplements\"\u003ebest-berberine guide\u003c\/a\u003e compares current official labels in detail. DoNotAge earns our first-place preference for a straightforward conventional formula, with the commercial relationship disclosed.\u003c\/p\u003e\n\u003ch2 id=\"buying-pack-size-and-bb10\"\u003eBuying, pack size and BB10\u003c\/h2\u003e\n\u003cp\u003eUse the \u003ca href=\"https:\/\/donotage.org\/pure-berberine?dna_link=1176\" rel=\"sponsored noopener\" target=\"_blank\"\u003eDoNotAge Pure Berberine link\u003c\/a\u003e and apply \u003cstrong\u003eBB10 for 10% off eligible purchases\u003c\/strong\u003e. Confirm the final price, pack size, shipping, subscription terms and exclusions at checkout. The link is an affiliate referral and purchases are completed with DoNotAge.\u003c\/p\u003e\n\u003cp\u003eA 366-capsule pack contains 366 one-capsule days or 183 two-capsule days; that is supply arithmetic, not personalized dosing advice. A starting price is not the price of every pack, and a discount should not be assumed to stack with every offer.\u003c\/p\u003e\n\u003ch2 id=\"our-recommendation\"\u003eOur recommendation\u003c\/h2\u003e\n\u003cp\u003eFor the reader who wants a straightforward 500 mg HCl capsule, DoNotAge is our preferred overall product proposition. Its value comes from a clear formula, practical unit size, manufacturer-reported quality standards and an understandable purchasing route.\u003c\/p\u003e\n\u003cp\u003eChoose it with a specific goal and realistic expectations. The \u003ca href=\"\/pages\/data-center-berberine\"\u003eBerberine Data Center\u003c\/a\u003e and the related guides make the evidence available beyond the purchase decision, including findings that are positive, limited or null.\u003c\/p\u003e","brand":"DoNotAge","offers":[{"title":"Default Title","offer_id":52576433307930,"sku":null,"price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1002\/8708\/6874\/files\/donotage-pure-berberine-500mg.jpg?v=1792669542","url":"https:\/\/biohackblueprint.org\/products\/donotage-pure-berberine-supplement","provider":"Biohack Blueprint","version":"1.0","type":"link"}